Category: Blog Post
Giving Tuesday 2022
Thank you to everyone that participated in Giving Tuesday 2022! Donations Last year on Giving Tuesday, people came together to…
🤚🏻 Five for Friday – Vietnam Veterans and Cholangiocarcinoma
Home / Blog / [wpbb post:title] Did you know Sheila Harrison was the first widow to have the Department of…
🤚🏻 Five for Friday – Five Caregiver Perspectives
Home / Blog / [wpbb post:title] November is National Family Caregiver Month (NFCM)! The Cholangiocarcinoma Foundation recognizes NFCM as a…
CCF's Discussion Board
Dear Friends, On October 12, 2005, my brother was diagnosed with cholangiocarcinoma. Thus began a journey I could not have…
Monthly Scientific Update – November 2022 (A recent study investigated the effects of PD-L1 expression on cancer cells and tumor-infiltrating immune cells in intrahepatic cholangiocarcinoma (CCA))
PD-L1 on Tumor-Infiltrating Immune Cells: A Potential Prognostic Biomarker for Cholangiocarcinoma Kelly Butler, Dr. Reham Abdel-Wahab Patients may develop cancer…
Patient Engagement and Cancer Genome Sequencing (PE-CGS) “Cancer Moonshot” Program
The research team at Washington University School of Medicine and the Alvin J. Siteman Cancer Center is partnering with the…
🤚🏻 Five for Friday – Meet Five CCA Physicians
Home / Blog / [wpbb post:title] The Cholangiocarcinoma Foundation realizes that the fastest way to advance research is by working…
🤚🏻 Five for Friday – Meet 5 CCA Scientists
Home / Blog / [wpbb post:title] Finding a cure for a disease as rare and complex as cholangiocarcinoma demands creative…
Cure Cholangiocarcinoma Think Tank (C2T2)
The Cholangiocarcinoma Foundation has published a white paper from the first Cure Cholangiocarcinoma Think Tank (C2T2 ) meeting, which gathered…
🤚🏻 Five for Friday – Meet Some of CCF's Valued Experts
Home / Blog / [wpbb post:title] Collaboration is essential for cholangiocarcinoma research. This month, join us in appreciating our medical…